When the domestic commercialized pet cloning technology has been developed for 6 years, the original unit price of hundreds of thousands is ushering in a wave of "big price cuts".

　　In a recent interview with the Red Star Capital Bureau, we learned that Hunan Cexiong Biotechnology Co., Ltd. (hereinafter referred to as "Cixiong Biotechnology"), Jingxinuo Valley Biotechnology Co., Ltd. (hereinafter referred to as "Sino Valley"), Keboya Gene Technology (hereinafter referred to as "Sino Valley") Tianjin) Co., Ltd. (hereinafter referred to as "Panji Gene"), etc. are all carrying out promotional activities, and their unit prices have been "halved".

　　Behind the "half cut" of the unit price, even if the gross profit margin can reach 50%, some companies have withdrawn from the market competition.

However, there are also companies that are seeking the "first share" of the track.

　　The unit price is "halved": cloned cats are 88,000 yuan/piece, and they can be further discounted

　　On August 30, Cexiong Biological customer service told the Red Star Capital Bureau that the company has a cat cloning activity of 88,000 yuan per cat, "If you decide to do it, we will help you apply for a discount with the company."

　　The staff of Sino Valley revealed that the price of its pet cloning activities has dropped to 128,000 yuan, and there is even a 50% discount on the limit; Panji Gene also said that the company's current pet cloning activity price has dropped to about 200,000 yuan , regardless of variety and size.

　　From the beginning of commercialization, the price of pet cloning technology is generally more than 200,000 yuan, and it is "cut" to tens of thousands of yuan.

　　The Red Star Capital Bureau noticed from the 2022-2023 version of the product manual obtained from Sino Valley that the cheapest pet cloning project is A-type cloned dogs, including 12 categories such as 10-12-month-old miniature poodles and Pomeranians. 220,000 yuan per dog; the most expensive is the E-type cloned dog, including 11 categories of 10-12 months Bernese Mountain, Caucasus, Alaska, etc., 450,000 yuan per dog.

　　Different from the quotation in the product manual, Mi Jidong, chairman/general manager of Sino Valley, told the Red Star Capital Bureau that the company's current unit price of pet clones is basically between 120,000 and 150,000 yuan.

The reason for the price reduction, it said, "The first is that the technical stability is increasing, and the second is that we hope that everyone will not have much burden in payment."

　　Pet Clone Track:

　　Gross profit margin may be as high as 50%, and there are still companies exiting

　　Although the unit price of pet cloning technology is declining, the price is generally hundreds of thousands or more, which makes most pet owners choose to repurchase or adopt a pet, which also makes some companies abandon the pet cloning track.

　　According to media reports, Zheng Shidong, CEO of Xiamen Ximan Gene Biotechnology Co., Ltd. (hereinafter referred to as "Ximan Gene"), once revealed that the cost of cloning a pet dog with Ximan Gene is about 100,000 yuan, and the profit per order is 50,000-100,000 yuan. Never wait.

According to the cloning price of 200,000 yuan, the gross profit margin of Seaman Gene's pet cloning business may reach 50% or more.

　　However, Zheng Shidong believes that the C-end business of Seaman Gene has only about a dozen orders per year, and it is mainly recommended by acquaintances.

In other words, the annual C-end business income of Seaman Gene is less than 2 million yuan.

Since then, affected by the epidemic and various restrictions on animal transportation, Himan Gene withdrew from the pet cloning business at the end of 2020.

　　On August 30, the Red Star Capital Bureau called Zheng Shidong's number announced on the Tianyancha APP. When the Red Star Capital Bureau asked if he was answering the call, the other party immediately hung up.

　　Regarding the cost and profit related issues of Sino Valley in the pet cloning business, Mi Jidong said that it is inconvenient to disclose because it involves some core data.

　　What is the future of the track?

　　not yet formed on a large scale

　　Mi Jidong said that domestic pet cloning may be able to compete with American companies with relatively mature technology in a few years, and the market space will reach 40 million US dollars. However, the pet cloning industry has not yet formed a large scale in the domestic market and is still relatively scattered.

　　It revealed that the current annual income of Sino Valley is about 30 million yuan, of which the pet cloning business accounts for 60%-70%, or about 20 million yuan.

Although some companies have withdrawn from the track, Mi Jidong is full of confidence in the future. "We have a plan to go public, and we hope to go public in three to five years." If Xinuo Valley completes the listing plan, it may become the "No. 1 pet clone in China". share".

　　However, the Red Star Capital Bureau has learned that during the pet cloning process, the number of embryos transferred is generally 5-10 at a time, but most of the surrogate animals are born with singletons.

Some embryos with poor quality and poor development will be naturally absorbed.

In this way, the survival rate of embryos is around 10%.

　　In this regard, Mi Jidong said frankly, "From the perspective of the entire cloning (industry), the overall efficiency is not high enough, and there is still room for improvement."

　　Chengdu Business Daily-Red Star News reporter Deng Lingyao